The Effects of Various Cooking Oils on Health Related Biomarkers in Healthy Subjects

NCT ID: NCT02599103

Last Updated: 2015-11-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

17 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-09-30

Study Completion Date

2015-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Fats and oils play important roles in maintaining human nutrition and health through providing energy, essential fatty acids, and acting as modulators of many biological processes (signal transduction, immunity and inflammation). Due to differences in the fatty acid composition and content of antioxidants of individual cooking oils, the degree of oxidative and thermolytic reactions may vary oil by oil. It is lack of human feeding study to investigate the molecular mechanisms on how and which deep-fried oil exerts its adverse effects. The investigators are also lack of biomarkers for monitoring deep-fried oil exposure. Therefore, the purpose of this study is to compare how human body responds differently to several popular uncooked and deep-fried oils with varied fatty acid compositions with respect of oxylipin profile, inflammatory markers, non-targeted metabolomics, and transcriptomics. The investigators will recruit 20 volunteers, provided them once a week the milk shakes prepared from 60g of olive oil, soybean oil, palm oil, camellia oil, tallow (butter), and deep-fried oils of the last 4, respectively; in comparison with a no-fat milk shake control. The experiments lasted for 10 weeks.。Each time; serum, plasma, whole blood and urine samples were collected at baseline, after 2 hours, and after 4 hours. The investigators anticipate to find biomarker(s) for deep-frying, and contribute to the understanding of molecular mechanisms on how deep-fried oils exert adverse effects toward health through integrative omics or so-called system biology approaches.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colorectal Neoplasms

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Participants Caregivers

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

fat-free milkshake

Group Type PLACEBO_COMPARATOR

Fat-free milkshake

Intervention Type OTHER

participants drinks a fat-free milk shakes

Olive oil

Group Type ACTIVE_COMPARATOR

Olive oil

Intervention Type OTHER

participants drinks the milk shakes prepared from 60g of olive oil

soybean oil

Group Type EXPERIMENTAL

Soybean oil

Intervention Type OTHER

participants drinks the milk shakes prepared from 60g of soybean oil

fried soybean oil

Group Type EXPERIMENTAL

Fried soybean oil

Intervention Type OTHER

participants drinks the milk shakes prepared from 60g of fried soybean oil

palm oil

Group Type EXPERIMENTAL

Palm oil

Intervention Type OTHER

participants drinks the milk shakes prepared from 60g of palm oil

fried palm oil

Group Type EXPERIMENTAL

Fried palm oil

Intervention Type OTHER

participants drinks the milk shakes prepared from 60g of fried palm oil

camellia oil

Group Type EXPERIMENTAL

Camellia oil

Intervention Type OTHER

participants drinks the milk shakes prepared from 60g of camellia oil

fried camellia oil

Group Type EXPERIMENTAL

Fried camellia oil

Intervention Type OTHER

participants drinks the milk shakes prepared from 60g of fried camellia oil

tallow

Group Type EXPERIMENTAL

Tallow

Intervention Type OTHER

participants drinks the milk shakes prepared from 60g of tallow

fried tallow

Group Type EXPERIMENTAL

Fried tallow

Intervention Type OTHER

participants drinks the milk shakes prepared from 60g of fried tallow

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Fat-free milkshake

participants drinks a fat-free milk shakes

Intervention Type OTHER

Olive oil

participants drinks the milk shakes prepared from 60g of olive oil

Intervention Type OTHER

Soybean oil

participants drinks the milk shakes prepared from 60g of soybean oil

Intervention Type OTHER

Fried soybean oil

participants drinks the milk shakes prepared from 60g of fried soybean oil

Intervention Type OTHER

Palm oil

participants drinks the milk shakes prepared from 60g of palm oil

Intervention Type OTHER

Fried palm oil

participants drinks the milk shakes prepared from 60g of fried palm oil

Intervention Type OTHER

Camellia oil

participants drinks the milk shakes prepared from 60g of camellia oil

Intervention Type OTHER

Fried camellia oil

participants drinks the milk shakes prepared from 60g of fried camellia oil

Intervention Type OTHER

Tallow

participants drinks the milk shakes prepared from 60g of tallow

Intervention Type OTHER

Fried tallow

participants drinks the milk shakes prepared from 60g of fried tallow

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Non-smoking, non-drinker, usual dietary intake
* BMI : 18.5\~27 kg/m2

Exclusion Criteria

1. Over the past two weeks have suffered from acute illness.
2. None of the subjects was taking any supplemental vitamins, antioxidants or medication at that time.
3. Taking steroids or non-steroidal anti-inflammatory drug, such as Aspirin or Panadol in the past one week.
4. Cancer or other severe diseases was diagnosed.
Minimum Eligible Age

20 Years

Maximum Eligible Age

50 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Academia Sinica, Taiwan

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Wen-Harn Pan

Institute of Biomedical Sciences

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Wen-Harn Pan, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

Institute of Biomedical Sciences, Academia Sinica

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AS-IRB02-102083

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Lipid Mediators & Cancer: Montelukast, SPM, and Almonds
NCT06887673 NOT_YET_RECRUITING EARLY_PHASE1